You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 13, October 3, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effects of Exposure to Factor Concentrates Containing Donations From Identified AIDS Patients

A Matched Cohort Study

Janine Jason, MD; Robert C. Holman, MS; Gloria Dixon, RN; Dale N. Lawrence, MD; Lorna H. Bozeman, MS; Terence L. Chorba, MD; Leslie Tregillus, MD; Bruce L. Evatt, MD; The Hemophilia/AIDS Collaborative Study Group

JAMA. 1986;256(13):1758-1762.


Abstract

We compared recipients of eight lots of factors VIII and IX voluntarily withdrawn from distribution because one donor was known to have subsequently developed the acquired immunodeficiency syndrome with a nonexposed cohort matched by age, sex, and factor use. The factor VIII recipient cohorts did not differ in prevalence of antibody to human immunodeficiency virus (HIV) (exposed, 75%; nonexposed, 86%), T-cell subset numbers (median: exposed, 619 T-helper cells per cubic millimeter; nonexposed, 659 T-helper cells per cubic millimeter), T-helper to T-suppressor ratios, or immunoglobulin levels. Exposed individuals had higher levels of immune complexes by C1q binding and staphylococcal binding assays and lower responses to phytohemagglutinin and concanavalin A. However, only the staphylococcal binding assay values were outside the normal range for our laboratory. Factor IX recipient cohorts did not differ in HIV antibody prevalence (exposed, 30%; nonexposed, 40%) or any immune tests. Although exposed and nonexposed individuals did not differ from each other in a clinically meaningful fashion at initial testing, both the exposed and nonexposed cohorts had high rates of HIV seroprevalence. Market withdrawals were clearly insufficient means of limiting the spread of HIV in hemophilic patients; however, the currently available methods of donor screening and viral inactivation of blood products will prevent continued exposure within this population.

(JAMA 1986;256:1758-1762)



Author Affiliations

From the Division of Host Factors, Center for Infectious Diseases, Centers for Disease Control, Department of Health and Human Services, Public Health Service, Atlanta.


Footnotes

Use of trade names and commercial sources is for identification only and does not imply endorsement by the Public Health Service or the US Department of Health and Human Services.

Reprint requests to Division of Host Factors, Center for Infectious Diseases, Centers for Disease Control, 1600 Clifton Rd, 1-1407, Atlanta, GA 30333 (Dr Jason).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pregnancies in Human Immunodeficiency Virus-Infected Sex Partners of Hemophilic Men
Jason and Evatt
Arch Pediatr Adolesc Med 1990;144:485-490.
ABSTRACT  

Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men
Jason et al.
JAMA 1989;261:725-727.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.